This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Koda, S. Articles by Nakazato, M. Search for Related Content PubMed PubMed Citation Articles by Koda, S. Articles by Nakazato, M.

The Role of the Vagal Nerve in Peripheral PYY_3–36-Induced Feeding Reduction in Rats

Third Department of Internal Medicine (S.K., Y.D., T.S., T.H., K.T., M.N.), Miyazaki Medical College, University of Miyazaki, Miyazaki 889-1692; Daiichi Suntory Biomedical Research Co., Ltd. (S.K., M.F., N.I.), Osaka 681-8513 Japan; Department of Veterinary Physiology (N.M.), Faculty of Agriculture, Miyazaki University, Miyazaki 889-2192; Department of Physiology, Niigata University School of Medicine (A.N.), Niigata 951-8510; and Daiichi Suntory Pharma Co., Ltd. (T.H., K.O.), Gunma 370-0503, Japan

Address all correspondence and requests for reprints to: Masamitsu Nakazato, M.D., Ph.D., Third Department of Internal Medicine, Miyazaki Medical College, University of Miyazaki, Kiyotake, Miyazaki 889-1692, Japan. E-mail: nakazato{at}med.miyazaki-u.ac.jp.

Peptide YY (PYY), an anorectic peptide, is secreted postprandially from the distal gastrointestinal tract. PYY_3–36, the major form of circulating PYY, binds to the hypothalamic neuropeptide Y Y2 receptor (Y2-R) with a high-affinity, reducing food intake in rodents and humans. Additional gastrointestinal hormones involved in feeding, including cholecystokinin, glucagon-like peptide 1, and ghrelin, transmit satiety or hunger signals to the brain via the vagal afferent nerve and/or the blood stream. Here we determined the role of the afferent vagus nerve in PYY function. Abdominal vagotomy abolished the anorectic effect of PYY_3–36 in rats. Peripheral administration of PYY_3–36 induced Fos expression in the arcuate nucleus of sham-operated rats but not vagotomized rats. We showed that Y2-R is synthesized in the rat nodose ganglion and transported to the vagal afferent terminals. PYY_3–36 stimulated firing of the gastric vagal afferent nerve when administered iv. Considering that Y2-R is present in the vagal afferent fibers, PYY_3–36 could directly alter the firing rate of the vagal afferent nerve via Y2-R. We also investigated the effect of ascending fibers from the nucleus of the solitary tract on the transmission of PYY_3–36-mediated satiety signals. In rats, bilateral midbrain transections rostral to the nucleus of the solitary tract also abolished PYY_3–36-induced reductions in feeding. This study indicates that peripheral PYY_3–36 may transmit satiety signals to the brain in part via the vagal afferent pathway.

This article has been cited by other articles:

				E. Karra, K. Chandarana, and R. L. Batterham The role of peptide YY in appetite regulation and obesity J. Physiol., January 1, 2009; 587(1): 19 - 25. [Abstract] [Full Text] [PDF]

				A. Geliebter, C. N. Ochner, and R. Aviram-Friedman Appetite-Related Gut Peptides in Obesity and Binge Eating Disorder American Journal of Lifestyle Medicine, July 1, 2008; 2(4): 305 - 314. [Abstract] [PDF]

				S. Unniappan and T. J. Kieffer Leptin extends the anorectic effects of chronic PYY(3-36) administration in ad libitum-fed rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R51 - R58. [Abstract] [Full Text] [PDF]

				R P Vincent and C W le Roux The satiety hormone peptide YY as a regulator of appetite J. Clin. Pathol., May 1, 2008; 61(5): 548 - 552. [Abstract] [Full Text] [PDF]

				J. R. C. Parkinson, W. S. Dhillo, C. J. Small, O. B. Chaudhri, G. A. Bewick, I. Pritchard, S. Moore, M. A. Ghatei, and S. R. Bloom PYY3-36 injection in mice produces an acute anorexigenic effect followed by a delayed orexigenic effect not observed with other anorexigenic gut hormones Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E698 - E708. [Abstract] [Full Text] [PDF]

				O. B. Chaudhri, K. Wynne, and S. R. Bloom Can Gut Hormones Control Appetite and Prevent Obesity? Diabetes Care, February 1, 2008; 31(Supplement_2): S284 - S289. [Abstract] [Full Text] [PDF]

				S. Hao, C. Sternini, and H. E. Raybould Role of CCK1 and Y2 receptors in activation of hindbrain neurons induced by intragastric administration of bitter taste receptor ligands Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R33 - R38. [Abstract] [Full Text] [PDF]

				K. L. Whited, P. Tso, and H. E. Raybould Involvement of Apolipoprotein A-IV and Cholecystokinin1 Receptors in Exogenous Peptide YY3 36-Induced Stimulation of Intestinal Feedback Endocrinology, October 1, 2007; 148(10): 4695 - 4703. [Abstract] [Full Text] [PDF]

				M. Sato, K. Nakahara, M. Miyazato, K. Kangawa, and N. Murakami Regulation of GH secretagogue receptor gene expression in the rat nodose ganglion J. Endocrinol., July 1, 2007; 194(1): 41 - 46. [Abstract] [Full Text] [PDF]

				I. Gantz, N. Erondu, M. Mallick, B. Musser, R. Krishna, W. K. Tanaka, K. Snyder, C. Stevens, M. A. Stroh, H. Zhu, et al. Efficacy and Safety of Intranasal Peptide YY3-36 for Weight Reduction in Obese Adults J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1754 - 1757. [Abstract] [Full Text] [PDF]

				N. Vrang, A. N. Madsen, M. Tang-Christensen, G. Hansen, and P. J. Larsen PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R367 - R375. [Abstract] [Full Text] [PDF]

				O. Chaudhri, C. Small, and S. Bloom Gastrointestinal hormones regulating appetite Phil Trans R Soc B, July 29, 2006; 361(1471): 1187 - 1209. [Abstract] [Full Text] [PDF]

				G. Burdyga, A. Varro, R. Dimaline, D. G. Thompson, and G. J. Dockray Ghrelin receptors in rat and human nodose ganglia: putative role in regulating CB-1 and MCH receptor abundance Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1289 - G1297. [Abstract] [Full Text] [PDF]

				P. K. Chelikani, A. C. Haver, J. R. Reeve Jr., D. A. Keire, and R. D. Reidelberger Daily, intermittent intravenous infusion of peptide YY(3-36) reduces daily food intake and adiposity in rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2006; 290(2): R298 - R305. [Abstract] [Full Text] [PDF]

				A. A. Young Obesity: A Peptide YY-Deficient, But Not Peptide YY- Resistant, State Endocrinology, January 1, 2006; 147(1): 1 - 2. [Full Text] [PDF]

				S. H. Adams, C. Lei, C. M. Jodka, S. E. Nikoulina, J. A. Hoyt, B. Gedulin, C. M. Mack, and E. S. Kendall PYY[3-36] Administration Decreases the Respiratory Quotient and Reduces Adiposity in Diet-Induced Obese Mice J. Nutr., January 1, 2006; 136(1): 195 - 201. [Abstract] [Full Text] [PDF]

				N. M. Neary, C. J. Small, M. R. Druce, A. J. Park, S. M. Ellis, N. M. Semjonous, C. L. Dakin, K. Filipsson, F. Wang, A. S. Kent, et al. Peptide YY3-36 and Glucagon-Like Peptide-17-36 Inhibit Food Intake Additively Endocrinology, December 1, 2005; 146(12): 5120 - 5127. [Abstract] [Full Text] [PDF]

				T. Talsania, Y. Anini, S. Siu, D. J. Drucker, and P. L. Brubaker Peripheral Exendin-4 and Peptide YY3-36 Synergistically Reduce Food Intake through Different Mechanisms in Mice Endocrinology, September 1, 2005; 146(9): 3748 - 3756. [Abstract] [Full Text] [PDF]

				Y. Date, K. Toshinai, S. Koda, M. Miyazato, T. Shimbara, T. Tsuruta, A. Niijima, K. Kangawa, and M. Nakazato Peripheral Interaction of Ghrelin with Cholecystokinin on Feeding Regulation Endocrinology, August 1, 2005; 146(8): 3518 - 3525. [Abstract] [Full Text] [PDF]